ACTIVE

APR Pharma

Export PDF
Financial year 2025 · closed on 31/12/2025
Net result
39,3 k €
+239.2% YoY
Gross margin
70,7 k €
+10689.7% YoY
Equity
93,5 k €
+2111.9% YoY

What does APR Pharma do?

APR Pharma is a Private limited company incorporated in 2020. Its main activity is: Manufacture of basic pharmaceutical products. Its registered office is in Courcelles.

Legal situation
● Normal situation
BCE/KBO no. / VAT
BE 0748.905.227
Incorporation
24/06/2020
Legal form
Private limited company
Registered office
Rue de Liège(CO) 2
6180 Courcelles · WallonieSee on map
Contributed capital
55 000,00 €
Latest accounts
31/12/2025
Activities (NACE)
21100Manufacture of basic pharmaceutical products· main21100Manufacture of basic pharmaceutical products10860Manufacture of homogenised food preparations and dietetic food10860Manufacture of homogenised food preparations and dietetic food10910Manufacture of prepared feeds for farm animals10910Manufacture of prepared feeds for farm animals+20
Signals
ProfitableSolid equityPositive cashflowPositive EBITDA
View the BCE/KBO Public Search record →
Health score
Available with a Rovalta subscriptionTry for 7 days
Recommended credit limit
✦ Verdict · Analyst summary
Financials

Trend over 5 financial years

20252024202320222021
Income statement
Gross margin70,7 k €-667,2 €-2,5 k €-172,2 k €-216,5 k €
EBITDA70 k €-1,1 k €-2,9 k €-172,6 k €-217,2 k €
Operating result39,3 k €-28,2 k €-27,9 k €-197,6 k €-241,9 k €
Net result39,3 k €-28,2 k €-27,9 k €-197,6 k €-242 k €
Balance sheet
Equity93,5 k €4,2 k €32,4 k €60,4 k €258 k €
Total assets245 k €263,1 k €239,2 k €309,8 k €394,3 k €
Cash46,4 k €65 k €29,3 k €100,5 k €163,4 k €
Debts151,4 k €258,8 k €206,7 k €249,4 k €136,3 k €
Estimate

Indicative valuation

As an indication, this company is worth

between 100 k€ and 250 k€
See the valuation
Governance

Board of directors

Seen on filing of 31/12/2025 · 4 active · 1 ended

Active mandates

CONSOLID

Director · since 23 juin 2020 · 0479.355.885

Represented by Dries Moens

Active
Joris Pieter De Gussem

Managing director · since 23 juin 2020

Active
Maarten De Gussem

Director · since 23 juin 2020

Active
RXW Group

Managing director · since 23 juin 2020 · 0505.854.901

Represented by Christiaan Willaert

Active

Ended mandates

Joris De Gussem

Managing director · since 23 juin 2020

Ended
At this address

Other companies at this address

CompanyCBE no.
CFG Pharma● Active
0746.821.410
EYTELIA● Active
0456.542.178
PHIDEX CALN● Active
0632.516.214
sil'innov● Active
0651.902.356
Annual accounts

Full financial information

20252024202320222021
Type of accountAbridged modelAbridged modelAbridged modelAbridged modelMicro model
Start of the financial year01/01/202501/01/202401/01/202301/01/202224/06/2020
Closing of the financial year31/12/202531/12/202431/12/202331/12/202231/12/2021
Length of the financial year12 months12 months12 months12 months19 months
Filing date19/08/202615/07/202524/06/202426/06/202329/08/2022
General meeting09/06/202610/06/202511/06/202413/06/202314/06/2022
Currency of the financial yearEUREUREUREUREUR
NBB quality labelSatisfying controlsSatisfying controlsSatisfying controlsSatisfying controlsSatisfying controls
Ratios

Financial ratios

Looking for more information about this company?

Try for 7 days
Filings

Annual accounts filings

5 filings with the NBB

ModelClosingGeneral meetingFiledLanguageDocument
Abridged model31/12/202509/06/202619/08/2026FrenchPDF
Abridged model31/12/202410/06/202515/07/2025FrenchPDF
Abridged model31/12/202311/06/202424/06/2024FrenchPDF
Abridged model31/12/202213/06/202326/06/2023FrenchPDF
Micro model31/12/202114/06/202229/08/2022FrenchPDF
Estimate

Indicative valuation

Order of magnitude

As an indication, this company is worth

between 100 k€ and 250 k€

The detail comes with the Business plan: low and high bounds, the valuation bridge for each financial year, transaction multiples by sector and size, group valuation and exports.

Discover the Business plan
Disclaimer

Indicative estimate based on public sector multiples and the filed annual accounts. It is neither a certified valuation nor financial or investment advice.

Governance

Board of directors

Seen on filing of 31/12/2025 · 4 active · 1 ended

Active mandates

CONSOLID

Director · since 23 juin 2020 · 0479.355.885

Represented by Dries Moens

Active
Joris Pieter De Gussem

Managing director · since 23 juin 2020

Active
Maarten De Gussem

Director · since 23 juin 2020

Active
RXW Group

Managing director · since 23 juin 2020 · 0505.854.901

Represented by Christiaan Willaert

Active

Ended mandates

Joris De Gussem

Managing director · since 23 juin 2020

Ended
Shareholders

Ownership and network

Looking for more information about this company?

Try for 7 days
Belgian Official Gazette

Belgian Official Gazette publications

  • Other10/11/2025
    DIVERS
    PDF
  • Other26/06/2020
    RUBRIQUE CONSTITUTION (NOUVELLE PERSONNE MORALE, OUVERTURE SUCCURSALE, ETC...)
    PDF

Source: Belgian Official Gazette

Competition

Similar companies

A company's peers, by sector and size, are included in the Business plan.

See the Business plan

Timeline

  1. 2025
    Annual accounts 202539,3 k €↑
  2. 2024
    Annual accounts 2024-28,2 k €↓
  3. 2023
    Annual accounts 2023-27,9 k €↑
  4. 2022
    Annual accounts 2022-197,6 k €↑
  5. 2021
    Annual accounts 2021-242 k €
  6. 24/06/2020
    IncorporationPrivate limited company